Search for: "State v. Price" Results 4461 - 4480 of 13,238
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2017, 12:15 pm by Mark Walsh
Amgen Inc., regarding the Biologics Price Competition and Innovation Act of 2009. [read post]
9 Jun 2017, 6:06 am
Mangino, Fried, Frank, Harris, Shriver & Jacobson LLP, on Friday, June 2, 2017 Tags: Appraisal rights, Auctions, Delaware cases, Delaware law, Fair values, Fairness review, Merger litigation, Mergers & acquisitions The Role of Social Capital in Corporations: A Review Posted by Henri Servaes, London Business School and Ane Tamayo, London School of Economics, on Saturday, June 3, 2017 Tags: Corporate culture, Corporate Social… [read post]
6 Jun 2017, 10:26 pm by Lisa Ouellette
What does Impression mean for pharmaceutical prices in the United States and abroad? [read post]
6 Jun 2017, 7:37 am by Dennis Crouch
And what does this have to do with Impression Products v. [read post]
6 Jun 2017, 5:00 am by John Jascob
The Second Circuit agreed with the district court that the plaintiff failed to demonstrate an objectively reasonable belief that the alleged pricing irregularities constituted a violation enumerated in the statute (Kantin v. [read post]
5 Jun 2017, 12:47 pm by Matthew Kahn
The Fourth Circuit ruled last week in IRAP v. [read post]